Recent review of COVID-19 management: Diagnosis, treatment and vaccination

VP Chavda, S Vuppu, T Mishra, S Kamaraj… - Pharmacological …, 2022 - Springer
The idiopathic Coronavirus disease 2019 (COVID-19) pandemic outbreak caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global …

Glucose metabolism disorder: a potential accomplice of SARS-CoV-2

Y Luan, Y Luan, H He, B Jue, Y Yang, B Qin… - International Journal of …, 2023 - nature.com
Abstract Globally, 265,713,467 confirmed cases of SARS-CoV-2 (CoV-2), including
5,260,888 deaths, have been reported by the WHO. It is important to study the mechanism of …

[HTML][HTML] Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19

M Wang, W Chang, L Zhang… - International Journal of …, 2022 - ncbi.nlm.nih.gov
The rapid dissemination of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the causative agent of coronavirus disease 2019 (COVID-19), remains a global public health …

Prevalence and mortality rate of healthcare-associated infections among COVID-19 patients: a retrospective cohort community-based approach

S Fakhreddine, M Fawaz, S Hassanein… - Frontiers in Public …, 2023 - frontiersin.org
Background The prevalence of HAI among COVID-19 patients ranged between 4.8% and
42.8% with the highest occurrence observed in critically ill patients. The present study aimed …

Recent clinical findings on the role of kinase inhibitors in COVID-19 management

Z Malekinejad, A Baghbanzadeh, A Nakhlband… - Life Sciences, 2022 - Elsevier
The highly pathogenic, novel coronavirus disease (COVID-19) outbreak has emerged as a
once-in-a-century pandemic with poor consequences, urgently calling for new therapeutics …

Neurological manifestations of SARS-CoV-2: Complexity, mechanism and associated disorders

K Tyagi, P Rai, A Gautam, H Kaur, S Kapoor… - European Journal of …, 2023 - Springer
Abstract Background Coronaviruses such as Severe Acute Respiratory Syndrome
coronavirus (SARS), Middle Eastern Respiratory Syndrome (MERS) and Severe Acute …

Pharmacological therapies and drug development targeting SARS-CoV-2 infection

Y Jiang, L Rubin, Z Zhou, H Zhang, Q Su… - Cytokine & Growth …, 2022 - Elsevier
The development of therapies for SARS-CoV-2 infection, based on virus biology and
pathology, and of large-and small-scale randomized controlled trials, have brought forward …

Repeated ethanol exposure and withdrawal alters angiotensin‐converting enzyme 2 expression in discrete brain regions: Implications for SARS‐CoV‐2 …

N Balasubramanian, TD James… - Alcohol: Clinical and …, 2023 - Wiley Online Library
Background People with alcohol use disorder (AUD) may be at higher risk for COVID‐19.
Angiotensin‐converting enzyme 2 (ACE2) and transmembrane serine protease 2 …

[HTML][HTML] The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and …

V Musazadeh, A Karimi, J Jafarzadeh, S Sanaie… - Biomedicine & …, 2022 - Elsevier
The proceeding pandemic of coronavirus disease 2019 is the latest global challenge. Like
most other infectious diseases, inflammation, oxidative stress, and immune system …

A brief overview of SARS-CoV-2 infection and its management strategies: a recent update

A Das, S Pathak, M Premkumar… - Molecular and Cellular …, 2023 - Springer
The COVID-19 pandemic has become a global health crisis, inflicting substantial morbidity
and mortality worldwide. A diverse range of symptoms, including fever, cough, dyspnea, and …